MitoP Cancer Research Results
MitoP, Mitophagy: Click to Expand ⟱
| Source: |
| Type: |
Mitophagy—the selective autophagic removal of damaged mitochondria—is now regarded as a core upstream process in Alzheimer’s disease pathophysiology, not a secondary epiphenomenon. Impairment of mitophagy precedes overt amyloid and tau pathology and helps explain early synaptic failure and neuronal vulnerability.
|
Scientific Papers found: Click to Expand⟱
*cardioP↑, *MitoP↑, *ROS↓, *mtDam↓, *neuroP↓, TumAuto↓, *AntiDiabetic↑,
TRPV2↑, Ca+2↑, MitoP↑, Synergy↑,
*NRF2↑, *NF-kB↓, *antiOx↑, *BP↝, *GutMicro↑, *Ingr?, *Synergy↑, *antiOx↑, *ROS↓, *toxicity↝, *MMP↑, *ATP↑, *MitoP↑, *lipid-P↓, *MDA↓, *SOD↑, *GPx↑, *TAC↑, *NK cell↑, *IFN-γ↑, *CRP↓, *SCFAs↑, *TC↓, *LDL↓, *TG/TAG↓, *toxicity↝, AntiTum↑, Ki-67↓, ER-α36↓, P53↑, P21↑, TumCCA↑, Bax:Bcl2↑, Apoptosis↑, Synergy↑,
*AntiP↑, AntiTum↑, ChemoSen↑, TumCP↓, TumCCA↑, cycD1/CCND1↓, mTOR↓, STAT3↑, Apoptosis↑, mtDam↑, ROS↑, MMP↓, OCR↓, MitoP↓,
| - |
in-vitro, |
neuroblastoma, |
SH-SY5Y |
|
|
|
*toxicity↑, TumCD↑, ROS↑, mtDam↑, Apoptosis↑, MitoP↑, TumAuto↑, p‑Akt↓, p‑mTOR↓, LC3II↑, Beclin-1/ATG6↑, ATG5↑, PINK1↑, PARK2↑, tumCV↓, MDA↑, SOD↑, Catalase↑, eff↓, MMP↓, BAX↑, cl‑Casp3↑, cl‑Casp9↑, cl‑PARP↑, Cyt‑c↑, Bcl-2↓, proCasp3↓, Bax:Bcl2↑, eff↑, *AntiP↑, *Inflam↓, *AntiDiabetic↑, *AntiViral↑, BBB∅, toxicity↝,
| - |
vitro+vivo, |
neuroblastoma, |
NA |
|
|
|
MMP↓, mtDam↑, ROS↑, PINK1↑, TumCG↓, OS↑, TumAuto↑, MitoP↑,
mtDam↑, Apoptosis↑, MitoP↑, Dose↝, Dose↝, eff↑, PINK1↑, PARK2↑,
tumCV↓, TumCMig↓, TumCI↓, CSCs↓, N-cadherin↓, Snail↓, Zeb1↓, SOX2↓, Nanog↓, OCT4↓, E-cadherin↑, ALDH↓, mtDam↑, MMP↓, compV↓, mt-ROS↑, PINK1↑, PARK2↑, AMPK↑, LC3A↑, LC3B↑, MFN2↓, MitoP↑, Apoptosis↑, Casp3↑, Casp9↑, Cyt‑c↑,
*MitoP↑, *NRF2↑, Synergy↑, *eff↓, *GutMicro↑,
ER Stress↑, UPR↑, autoF↓, lysosome↝, ROS↑, lipid-P↑, CSCs↓, necrosis↑, ATP↓, MMP↓, MOMP↑, DNAdam↑, AIF↑, lysoMP↑, MitoP↑, Ca+2↑,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
T98G |
|
|
|
- |
in-vitro, |
GBM, |
A172 |
|
|
|
TumAuto↑, ROS↑, TumCD↑, tumCV↓, selectivity↑, MMP↓, eff↓, MitoP↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*MitoP↑, *Inflam↓, *antiOx↑, *Risk↓, *Aβ↓, *p‑tau↓, *p62↓, *PARK2↑, *MMP↑, *ROS↓, *Strength↑, *CRP↓, *IL1β↓, *IL6↓, *TNF-α↓, *AMPK↑, *NF-kB↓, *MAPK↓, *p62↑, *NRF2↑, *SOD↑, *Catalase↑, *HO-1↑, *Ferroptosis↓, *lipid-P↓, *Cartilage↑, *PI3K↓, *Akt↓, *mTOR↓, *Apoptosis↓, *neuroP↑, *Bcl-2↓, *BAX↑, *Casp3↑, *ATP↑, *Synergy↑, *motorD↑, *NLRP3↓, *radioP↑, *BBB↑,
*memory↑, *Aβ↓, *tau↓, *MitoP↑, *lysosome↑, *CTSZ↝,
*neuroP↑, *Half-Life↝, *BBB↑, *toxicity↓, *Inflam↓, *Strength↑, *BACE/β-secretase↓, *Aβ↓, *MitoP↑, *SIRT1↑, *SIRT3↑, *AMPK↑, *PGC-1α↑, *mTOR↓, *PARK2↑, *Beclin-1/ATG6↑, *ROS↓, *GutMicro↑, *Risk↓,
*motorD↑, *memory↑, *MitoP↑, *Aβ↓, *mitResp↑, *Nrf1↑, *PINK1↑, *PARK2↑, *ATG5↑, *Bcl-2↑, *H2O2↓, *ROS↓, *lipid-P↓, *mt-ATP↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
ostP, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*MitoP↓, *Strength↑, *PINK1↑, *PARK2↑, *Inflam↓, *COX2/PTGS2↓, *IL1β↓, *IL6↓, *TNF-α↓, *OS↑, *cardioP↑, *memory↑, *neuroG↑, *neuroP↑, *Cartilage↑, *Inflam↓, *RenoP↑, *BioAv↑, *Dose↝, *Half-Life↑, *NRF2↑, *GutMicro↑, *chemoP↑,
*cognitive↑, *memory↑, *antiOx↑, *BBB↑, *ROS↓, *lipid-P↓, *Catalase↑, *SOD↑, *GSR↑, *GPx↑, *CREB↑, *BDNF↑, *neuroP↑, *Inflam↓, *MitoP↑, *Aβ↓, *tau↓, *NLRP3↓, *SIRT1↑, *SIRT3↑,
Showing Research Papers: 1 to 17 of 17
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 17
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↑, 1, lipid-P↑, 1, MDA↑, 1, ROS↑, 5, mt-ROS↑, 1, SOD↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compV↓, 1, MFN2↓, 1, mtDam↑, 5, OCR↓, 1, PINK1↑, 4,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, ATP↓, 1,
Cell Death(tgid=5) ⓘ
AIF↑, 1, Apoptosis↑, 5, BAX↑, 1, Bax:Bcl2↑, 2, Bcl-2↓, 1, Casp3↑, 1, cl‑Casp3↑, 1, proCasp3↓, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 2, MOMP↑, 1, necrosis↑, 1, TumCD↑, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
p‑Akt↓, 1, mTOR↓, 1, p‑mTOR↓, 1, STAT3↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
OCT4↓, 1, SOX2↓, 1, tumCV↓, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, UPR↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG5↑, 1, autoF↓, 1, Beclin-1/ATG6↑, 1, LC3A↑, 1, LC3B↑, 1, LC3II↑, 1, lysoMP↑, 1, lysosome↝, 1, MitoP↓, 1, MitoP↑, 7, PARK2↑, 3, TumAuto↓, 1, TumAuto↑, 3,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, Ki-67↓, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ALDH↓, 1, CSCs↓, 2, Ki-67↓, 1, Nanog↓, 1, TumCG↓, 1, TumCP↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 2, E-cadherin↑, 1, N-cadherin↓, 1, Snail↓, 1, TumCI↓, 1, TumCMig↓, 1, Zeb1↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB∅, 1, MMP↓, 6, TRPV2↑, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
ER-α36↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 2, eff↓, 2, eff↑, 2, selectivity↑, 1, Synergy↑, 3,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 2, OS↑, 1, toxicity↝, 1,
Total Targets: 82
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 4, Catalase↑, 2, GPx↑, 2, GSR↑, 1, H2O2↓, 1, HO-1↑, 1, lipid-P↓, 4, MDA↓, 1, Nrf1↑, 1, NRF2↑, 4, ROS↓, 6, SOD↑, 3, TAC↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mitResp↑, 1, mtDam↓, 1, PGC-1α↑, 1, PINK1↑, 2, SIRT3↑, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 2, ATP↑, 2, mt-ATP↑, 1, LDL↓, 1, SCFAs↑, 1, SIRT1↑, 2,
Cell Death(tgid=5) ⓘ
Apoptosis↓, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-2↑, 1, Casp3↑, 1, Ferroptosis↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 1, CREB↑, 1, MAPK↓, 1, mTOR↓, 2, PI3K↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG5↑, 1, Beclin-1/ATG6↑, 1, CTSZ↝, 1, lysosome↑, 1, MitoP↓, 1, MitoP↑, 8, p62↓, 1, p62↑, 1, PARK2↑, 4,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
neuroG↑, 1,
Migration(tgid=13) ⓘ
Cartilage↑, 2,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 3, MMP↑, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, IFN-γ↑, 1, IL1β↓, 2, IL6↓, 2, Inflam↓, 6, NF-kB↓, 2, NK cell↑, 1, NLRP3↓, 2, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
BDNF↑, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 5, BACE/β-secretase↓, 1, tau↓, 2, p‑tau↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, Dose↝, 1, eff↓, 1, Half-Life↑, 1, Half-Life↝, 1, Synergy↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
BP↝, 1, CRP↓, 2, IL6↓, 2, TC↓, 1, TG/TAG↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 2, cardioP↑, 2, chemoP↑, 1, cognitive↑, 1, memory↑, 4, motorD↑, 2, neuroP↓, 1, neuroP↑, 4, OS↑, 1, radioP↑, 1, RenoP↑, 1, Risk↓, 2, Strength↑, 3, toxicity↓, 1, toxicity↑, 1, toxicity↝, 2,
Infection & Microbiome(tgid=24) ⓘ
AntiP↑, 2, AntiViral↑, 1, GutMicro↑, 4,
Ingredients & Constituents(tgid=25) ⓘ
Ingr?, 1,
Total Targets: 93
Scientific Paper Hit Count for: MitoP, Mitophagy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1406 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page